Skip to main content

Determinants of hepatitis B and delta virus host tropism

Author(s): Winer, Benjamin Y; Ploss, Alexander

To refer to this page use:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWiner, Benjamin Y-
dc.contributor.authorPloss, Alexander-
dc.identifier.citationWiner, Benjamin Y, Ploss, Alexander. (2015). Determinants of hepatitis B and delta virus host tropism. Current Opinion in Virology, 13 (109 - 116. doi:10.1016/j.coviro.2015.06.004en_US
dc.description.abstractHepatitis B virus (HBV) infections are a global health problem afflicting approximately 360 million patients. Of these individuals, 15–20 million are co-infected with hepatitis delta virus (HDV). Progress towards curative therapies has been impeded by the highly restricted host tropism of HBV, which is limited to productive infections in humans and chimpanzees. Here, we will discuss different approaches that have been taken to study HBV and HDV infections in vivo. The development of transgenic and humanized mice has lead to deeper insights into HBV pathogenesis. An improved understanding of the determinants governing HBV and HDV species tropism will aid the construction of a small animal model with inheritable susceptible to HBV/ HDV.en_US
dc.format.extent109 - 116en_US
dc.relation.ispartofCurrent Opinion in Virologyen_US
dc.rightsAuthor's manuscripten_US
dc.titleDeterminants of hepatitis B and delta virus host tropismen_US
dc.typeJournal Articleen_US

Files in This Item:
File Description SizeFormat 
Determinants_hepatitis_b_host_tropism.pdf1.01 MBAdobe PDFView/Download

Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.